3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
15
Recurrence
8
Hodgkin Disease
6
Breast Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
5
Sezary Syndrome
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Mycosis Fungoides
4
Leukemia, Myeloid, Acute
4
Leukemia
4
Waldenstrom Macroglobulinemia
3
Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Prostatic Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Immunoblastic Lymphadenopathy
2
Glioma
2
Diffuse Intrinsic Pontine Glioma
2
Carcinoma, Renal Cell
2
Interventions
Cisplatin
4
pembrolizumab
3
Nivolumab
3
Fluorouracil
2
Carboplatin
2
toripalimab
1
spartalizumab
1
fludarabine phosphate
1
fludarabine
1
cc-486
1
camrelizumab
1
Vorinostat
1
Valganciclovir
1
Range of Motion, Articular
1
Radiotherapy
1
Radiosurgery
1
Protons
1
Platinum
1
Methylprednisolone
1
Medicare Part B
1
Laryngoscopes
1
Gemcitabine
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Bevacizumab
1
Azacitidine
1
Adrenal Cortex Hormones
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Nasopharyngeal Carcinoma
×
Panobinostat
×
Clear all
No trials found.